Krista Davis Ani Pharmaceuticals Inc (ANIP) insider trading activity

Krista Davis is SVP, CHIEF HR OFFICER of ANI PHARMACEUTICALS INC. Currently has a direct ownership of 58,564 shares of ANIP, which is worth approximately $4.92 Million. The most recent transaction as insider was on Dec 18, 2025, when has been sold 1,622 shares (Common Stock) at a price of $82.4 per share, resulting in proceeds of $133,652. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 58.6K

2.69% 3M change

19.37% 12M change

Total Value Held $4.92 Million

Krista Davis Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 18 2025	SELL Open market or private sale	$133,652 $82.4 p/Share	1,622 Reduced 2.69%	58,564 Common Stock
Sep 19 2025	SELL Open market or private sale	$98,040 $98.04 p/Share	1,000 Reduced 1.63%	60,186 Common Stock
Sep 12 2025	SELL Payment of exercise price or tax liability	$167,084 $97.71 p/Share	1,710 Reduced 2.72%	61,186 Common Stock
Aug 22 2025	SELL Open market or private sale	$160,609 $91.1 p/Share	1,763 Reduced 2.73%	62,896 Common Stock
Mar 19 2025	SELL Open market or private sale	$121,290 $65.0 p/Share	1,866 Reduced 2.8%	64,659 Common Stock
Mar 07 2025	SELL Open market or private sale	$60,860 $60.86 p/Share	1,000 Reduced 1.48%	66,525 Common Stock
Feb 28 2025	SELL Payment of exercise price or tax liability	$68,017 $61.89 p/Share	1,099 Reduced 1.6%	67,525 Common Stock

Feb 21 2025	SELL Open market or private sale	$60,200 $60.2 p/Share	1,000 Reduced 1.44%	68,624 Common Stock
Feb 14 2025	SELL Payment of exercise price or tax liability	$70,468 $58.92 p/Share	1,196 Reduced 1.69%	69,624 Common Stock
Feb 12 2025	BUY Grant, award, or other acquisition	-	21,761 Added 23.5%	70,820 Common Stock
Dec 11 2024	SELL Open market or private sale	$60,000 $60.0 p/Share	1,000 Reduced 2.0%	49,059 Common Stock
Sep 12 2024	SELL Payment of exercise price or tax liability	$83,438 $56.15 p/Share	1,486 Reduced 2.88%	50,059 Common Stock
Feb 29 2024	SELL Payment of exercise price or tax liability	$79,376 $67.67 p/Share	1,173 Reduced 2.23%	51,545 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	20,131 Added 27.63%	52,718 Common Stock
Nov 15 2023	SELL Open market or private sale	$141,089 $53.81 p/Share	2,622 Reduced 7.45%	32,587 Common Stock
Sep 12 2023	SELL Payment of exercise price or tax liability	$91,998 $61.91 p/Share	1,486 Reduced 4.05%	35,209 Common Stock
Feb 28 2023	BUY Grant, award, or other acquisition	-	20,262 Added 35.57%	36,695 Common Stock
Sep 12 2022	BUY Grant, award, or other acquisition	-	16,433 Added 50.0%	16,433 Common Stock

Krista Davis

SVP, CHIEF HR OFFICER

Baudette, MN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANIP shares.

Notify only if

Value

Insider Trading

Get notified when an Ani Pharmaceuticals Inc insider buys or sells ANIP shares.

Notify only if

Operation

Value

Type

News

Receive news related to ANI PHARMACEUTICALS INC

Track Activities on ANIP

Account